about
Linoleic acid metabolite drives severe asthma by causing airway epithelial injuryClinical usefulness of mepolizumab in severe eosinophilic asthmaQuantitative computed tomography imaging of airway remodeling in severe asthmaThe past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review.Using Periostin as a Biomarker in the Treatment of AsthmaNational Athletic Trainers' Association position statement: management of asthma in athletes.Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a reviewStrategies of mucosal immunotherapy for allergic diseasesQualitative analysis of high-resolution CT scans in severe asthmaCharacterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults.Noninvasive ventilation in acute respiratory failure.Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.Vital capacity and inspiratory capacity as additional parameters to evaluate bronchodilator response in asthmatic patients: a cross sectional studyAge-of-asthma onset as a determinant of different asthma phenotypes in adults: a systematic review and meta-analysis of the literature.Recommendation for optimal management of severe refractory asthma.IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?Induced Sputum Substance P in Children with Difficult-to-Treat Bronchial Asthma and Gastroesophageal Reflux: Effect of Esomeprazole Therapy.Steroid response in refractory asthmaticsPediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokinesAsthma Economic Costs in Adult Asthmatic Patients in Tehran, Iran.Bidirectional Counterregulation of Human Lung Mast Cell and Airway Smooth Muscle β2 Adrenoceptors.Update in asthma 2005.A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthmaAdjusted subpixel method enables optimisation of bronchial measurements in high-resolution CT.Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.Macrophage heterogeneity in respiratory diseases.Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells.Chemokines and their receptors as potential targets for the treatment of asthma.Mitochondrial dysfunction in metabolic syndrome and asthma.An overview of chronic severe asthma.beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.Contemporaneous International Asthma Guidelines Present Differing Recommendations: An AnalysisThe link between allergic rhinitis and asthma: a role for antileukotrienes?The role of autophagy in allergic inflammation: a new target for severe asthmaInvestigation of the anti‑asthmatic activity of Oridonin on a mouse model of asthma.Ultrastructural changes of airway in murine models of allergy and diet-induced metabolic syndrome.The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy.Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy.
P2860
Q21128677-F10BB32D-DB7B-43E0-AE95-20CAAE16AA34Q26746215-C8F9349E-C9EE-4AD7-AB2B-5CE901E08880Q26765050-821998D9-DE53-436E-A3CC-C7F2CCDAFC1AQ26775861-4B5ABAC3-9DBC-4648-907F-63EEE2024240Q28067637-D8A52679-6B73-46FF-8830-F792A048D8F1Q28769235-10C776CA-F19B-42D2-BA31-67DE9529C9BEQ30433207-8E9569BE-9457-4773-8B0A-CD3B71A80F92Q30801642-0E3C9ADB-68EA-4A07-A87D-5E98ECF1F22CQ33577679-015D529C-23CD-4FDB-BCF5-652622B12911Q33632072-C5EB1614-0AD9-4287-845E-2744F1840620Q33725032-A9680468-2290-4123-B5A0-FC74F8873E9BQ33836132-018FAA78-6649-461B-99F7-5AD66E37E1CCQ34062237-B3362A92-FDC8-4ACF-BC33-AC7B8303D0E2Q34289144-0F0DD2B4-175C-4E0A-B9B5-63003268A8AAQ34403827-5D261F90-CF6D-4CBD-B55C-ACE9480B4003Q34458002-FA2854C9-EA5F-45FB-A417-262B2F8A735CQ34620187-DC0AE136-0121-4F09-8B41-231053947310Q35129625-C62F4AE8-9550-4BFD-ACBC-0A507222E42EQ35664372-D37E0A88-2B86-4BA4-B585-94D2E105C97DQ36025200-B856DAB2-AD52-4C7E-A603-8747C82DA6EBQ36054219-EF28F270-5F95-4C43-8089-2B080B64D9D7Q36282175-141526F2-9B46-47F0-AAAA-56B0E3E3D5ADQ36389176-DC75CB5D-6384-46D3-88E2-21B4F1FBCA5BQ36429918-4927CB6E-F73C-404A-94B7-8B1C90D372D8Q36642971-976E22FB-ECAD-4188-A1FC-15C5B0303F53Q36653251-44D791AF-4B70-4463-9FE9-893B311FA62DQ36687379-A0FE51BC-0D59-413A-9F19-4CBE1CF95399Q36692041-B2E16821-51A1-4A44-BB09-9834AF11A866Q36736508-A097BD70-0925-44E9-97B9-92E6D9D22C10Q36807456-5D6BC08E-B281-41BE-826F-93C384B48C47Q36942788-9A83EDA7-E805-4B1C-8B59-28ADFF4784F3Q37008989-D5FAD690-5C9B-42AF-A7B3-FBF5BEF81342Q37013051-8D9C6A64-4D8A-4041-876F-A4C63FA21012Q37072879-C3BFEBB9-2599-45CF-B09F-1C923A3CB667Q37114633-3F68476F-361C-4E62-83B9-268434D03225Q37151423-001A891E-2649-48B9-BEF7-B9946D479423Q37191038-C2189552-AD9B-4B1E-90B7-5828C4543A34Q37196936-E8141222-6D93-42BF-BF2E-68FF4CD451DCQ37395286-105CB0DE-B17B-47B8-9817-628525B942A1Q37423141-1D49E0DC-C442-4DA7-AE66-78149F1815EC
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Severe asthma in adults.
@ast
Severe asthma in adults.
@en
type
label
Severe asthma in adults.
@ast
Severe asthma in adults.
@en
prefLabel
Severe asthma in adults.
@ast
Severe asthma in adults.
@en
P2860
P1476
Severe asthma in adults.
@en
P2093
Sally Wenzel
P2860
P304
P356
10.1164/RCCM.200409-1181PP
P407
P577
2005-04-22T00:00:00Z